2024
Evidence-based guideline: Premature Ovarian Insufficiency † ‡
ESHRE A, Yeganeh L, Giri R, Flanagan M, Panay N, Anderson R, Bennie A, Cedars M, Davies M, Ee C, Gravholt C, Kalantaridou S, Kallen A, Kim K, Misrahi M, Mousa A, Nappi R, Rocca W, Ruan X, Teede H, Vermeulen N, Vogt E, Vincent A. Evidence-based guideline: Premature Ovarian Insufficiency † ‡. Fertility And Sterility 2024 PMID: 39652037, DOI: 10.1016/j.fertnstert.2024.11.007.Peer-Reviewed Original ResearchHealth care professionalsCentre for Research ExcellencePremature ovarian insufficiencyProvision of careGuideline development groupCare professionalsRandomised controlled trialsDiagnosis of premature ovarian insufficiencyAnti-Mullerian hormoneBritish Menopause SocietyData Safety Monitoring BoardHormone therapyInternational Menopause SocietyBayer PharmaScoping surveyAmerican Society for Reproductive MedicineWomen's healthConsulting feesMenopause SocietyReproductive Scientist Development ProgramAdvisory boardOvarian insufficiencyAttending meetingsClinical questionsSurvey of womenEvidence-based guideline: premature ovarian insufficiency†‡
ASRM C, Panay N, Anderson R, Bennie A, Cedars M, Davies M, Ee C, Gravholt C, Kalantaridou S, Kallen A, Kim K, Misrahi M, Mousa A, Nappi R, Rocca W, Ruan X, Teede H, Vermeulen N, Vogt E, Vincent A. Evidence-based guideline: premature ovarian insufficiency†‡. Climacteric 2024, 27: 510-520. PMID: 39647506, DOI: 10.1080/13697137.2024.2423213.Peer-Reviewed Original ResearchConceptsProvision of careGuideline development groupAnti-Mullerian hormoneFollicle stimulating hormoneHealthcare professionalsHormone therapyScoping surveyClinical questionsSurvey of womenElevated follicle stimulating hormoneFollicle stimulating hormone measurementsEuropean Society of Human Reproduction and Embryology (ESHREDevelopment groupQuality of lifeRandomized controlled trialsCombined oral contraceptivesPractice careGeneral well-beingAnti-Mullerian hormone testCognitive healthIntegrative reviewNon-hormonal treatmentsESHRE Executive CommitteeWomen's healthMuscle healthEvidence-based guideline: premature ovarian insufficiency,
Panay N, Anderson R, Bennie A, Cedars M, Davies M, Ee C, Gravholt C, Kalantaridou S, Kallen A, Kim K, Misrahi M, Mousa A, Nappi R, Rocca W, Ruan X, Teede H, Vermeulen N, Vogt E, Vincent A, Yeganeh L, Giri R, Flanagan M. Evidence-based guideline: premature ovarian insufficiency,. Human Reproduction Open 2024, 2024: hoae065. PMID: 39660328, PMCID: PMC11631070, DOI: 10.1093/hropen/hoae065.Peer-Reviewed Original ResearchHealth care professionalsClinical practice guidelinesCentre for Research ExcellencePremature ovarian insufficiencyProvision of careGuideline development groupCare professionalsDiagnosis of premature ovarian insufficiencyAnti-Mullerian hormoneAmerican Society for Reproductive MedicineBritish Menopause SocietyData Safety Monitoring BoardRandomized controlled trialsPractice guidelinesInternational Menopause SocietyHormone therapyScoping surveyBayer PharmaWomen's healthConsulting feesMenopause SocietyReproductive Scientist Development ProgramAdvisory boardOvarian insufficiencyAttending meetings
2020
The relationship between H19 and parameters of ovarian reserve
Xia X, Burn MS, Chen Y, Karakaya C, Kallen A. The relationship between H19 and parameters of ovarian reserve. Reproductive Biology And Endocrinology 2020, 18: 46. PMID: 32404103, PMCID: PMC7218823, DOI: 10.1186/s12958-020-00578-z.Peer-Reviewed Original ResearchConceptsOvarian reserveDecreased ovarian reserveOocyte retrievalH19 expressionInfertility evaluationCumulus cellsTransvaginal oocyte retrievalDiminished ovarian reserveAnti-Mullerian hormoneDownregulation of H19H19 expression levelsGazi University SchoolParticipantsA totalAMH levelsSerum AMHIVF patientsOocyte yieldLow respondersBlood samplesNovel biomarkersExpression levelsFurther studiesPatientsUniversity SchoolH19